Serum long non-coding RNAs (lncRNAs) are emerging as promising biomarkers for various human diseases. The aim of this study was to investigate the feasibility of using serum long intergenic non-coding RNA-p21 (lincRNA-p21) as a biomarker for chronic hepatitis B patients. Serum lincRNA-p21 levels were quantified using real-time PCR in 417 CHB patients and 363 healthy controls. The promoter methylation level of lincRNA-p21 was detected using bisulphite-sequencing analysis in primary hepatic stellate cells (HSCs). Sera from hepatitis B-infected patients contained lower levels of lincRNA-p21 than sera from healthy controls. Serum lincRNA-p21 levels negatively correlated with stages of liver fibrosis in infected patients. Receiver operating characteristic (ROC) curve analyses suggested that serum lincRNA-p21 had a significant diagnostic value for liver fibrosis in these patients. It yielded an area under the curve of ROC of 0.854 with 100% sensitivity and 70% specificity in discriminating liver fibrosis from healthy controls. There was additionally a negative correlation between serum lincRNA-p21 level and the markers of liver fibrosis including α-SMA and Col1A1. However, there was no correlation of serum lincRNA-p21 level with the markers of viral replication, liver inflammatory activity, and liver function. Notably, during primary HSCs culture, loss of lincRNA-p21 expression was associated with promoter methylation. Serum lincRNA-p21 could serve as a potential biomarker of liver fibrosis in CHB patients. Down-regulation of lincRNA-p21 in liver fibrosis may be associated with promoter methylation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jvh.12680 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
LINC-p21 Regulates Pancreatic β-Cell Function in Type 2 Diabetes Mellitus.
Biochem Genet
June 2024
Department of Clinical Laboratory, Wuhu Hospital Affiliated to Anhui University of Science and Technology (The First People's Hospital of Wuhu), Wuhu, 241000, Anhui, China.
Article Synopsis
- The study focuses on the role of long intergenic non-coding RNA (LINC-p21) in type 2 diabetes mellitus (T2DM) by analyzing its expression in diabetic patients and mouse models, suggesting a strong link to T2DM prognosis.
- LINC-p21 was found to interact with miR-335-3p and IGF-1, indicating that these molecules may be involved in the protective effects on pancreatic β-cells under high glucose conditions.
- The findings suggest that targeting the miR-335-3p/IGF-1 axis could be a potential therapeutic approach for improving insulin production and managing T2DM progression.
Expression Analysis of Five Different Long Non-Coding Ribonucleic Acids in Nonsmall-Cell Lung Carcinoma Tumor and Tumor-Derived Exosomes.
Diagnostics (Basel)
December 2022
Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9177899191, Iran.
Article Synopsis
- Long non-coding RNAs (LncRNAs) play a crucial role in gene regulation and cancer development, particularly in non-small cell lung cancer (NSCLC).
- A study analyzed the expression of five specific LncRNAs in tumor tissues, adjacent non-cancerous tissues, and serum exosomes from 168 NSCLC patients, revealing significant expression differences.
- The findings suggest that LncRNAs GHSROS, HNF1A-AS1, and HOTAIR are upregulated in tumor tissues, while HMlincRNA717 and LINCRNA-p21 are downregulated; this LncRNA panel may enhance NSCLC diagnosis accuracy.
Serum lincRNA-p21 expression in primary liver diseases and liver metastatic diseases.
Pathol Res Pract
April 2019
Department of Clinical Laboratory, The Second Hospital, Shandong University, Jinan, Shandong, China. Electronic address:
Background: LincRNA-p21 is involved in the initiation and progression of many human diseases. We aimed to investigate the expression of LincRNA-p21 in different types of liver diseases.
Methods: Serum from patients with primary liver diseases (chronic HBV or HCV infection, hepatitis B virus-related cirrhosis, hepatitis B virus-related HCC, non-HBV/HCV-related HCC, alcoholic liver disease) and HBV negative liver metastatic cancer and control healthy individuals was collected and serum lincRNA-p21 levels were determined by RT-qPCR.
Role of lincRNA‑p21 in the protective effect of macrophage inhibition factor against hypoxia/serum deprivation‑induced apoptosis in mesenchymal stem cells.
Int J Mol Med
October 2018
Department of Radiation Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.
Stem cell transplantation is a promising clinical strategy for curing ischemic cardiomyopathy. However, its efficacy is impaired by low cell survival following transplantation, partly caused by insufficient resistance of the transplanted stem cells to severe oxidative stress at the injury site. In the current study, it was demonstrated that the small‑molecule macrophage migration inhibitory factor (MIF) enhanced the defense of bone marrow‑derived mesenchymal stem cells (MSCs) against hypoxia/serum deprivation (SD)‑induced apoptosis in vitro.
View Article and Find Full Text PDFSerum lincRNA-p21 as a potential biomarker of liver fibrosis in chronic hepatitis B patients.
J Viral Hepat
July 2017
Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Serum long non-coding RNAs (lncRNAs) are emerging as promising biomarkers for various human diseases. The aim of this study was to investigate the feasibility of using serum long intergenic non-coding RNA-p21 (lincRNA-p21) as a biomarker for chronic hepatitis B patients. Serum lincRNA-p21 levels were quantified using real-time PCR in 417 CHB patients and 363 healthy controls.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!